Mechanistically, POU2F2 activated PI3K/AKT/mTOR pathway to leading a metabolic shift towards aerobic glycolysis and promoting GBM progression in a PDPK1-dependent manner. The gene discussed is POU2F2; the disease is glioblastoma.